Global pharmaceutical company AstraZeneca is set to make a $15 billion investment in China through 2030 to expand its manufacturing and research and development capabilities in the country.
Archives
Interview: Jason Powell, CEO of UK Vein Clinic
HBI talks to Jason Powell, CEO of UK Vein Clinic, a low-cost outpatient chain for vericose vein treatment on the company's national expansion and the UK vein care market. UK Vein Clinic has announced plans to expand its network, with the launch of 17 new clinics in 2026.
February 5, 2026
Siegfried acquires Noramco, Extractas Biosciences, and Purisys from SK Capital
Siegfried, a Switzerland-headquartered pharma Contract Development and Manufacturing Organisation (CDMO), is acquiring three businesses from private equity firm SK Capital: the pharma company Normaco Group, Purisys, a CDMO partner for custom APIs, and Extractas Bioscience, a Tasmania-based botanicals manufacturer.
February 5, 2026
Bupa and HCF likely to lobby against Ramsay’s acquisition of NCPH from Healthscope
Private health insurer Bupa and publicly listed not-for-profit insurer HCF are reportedly preparing to lobby the Australian Competition and Consumer Commission (ACCC) to block the acquisition of Canberra-based National Capital Private Hospital (NCPH) by Australia’s largest for-profit hospital group, Ramsay Health Care.
February 4, 2026
Worldwide Clinical Trials acquires Catalyst Clinical Research
Worldwide Clinical Trials, a US-based contract research organisation (CRO) backed by private equity firm Kohlberg, has agreed to acquire specialised oncology CRO Catalyst Clinical Research from private equity firm QHP Capital.
February 2, 2026
Affidea acquires majority stake in LabPoint from Lindenhofgruppe
Affidea, a pan-European diagnostics and outpatient service provider, has acquired a majority stake in Swiss medical diagnostics laboratory firm LabPoint from Switzerland-based private hospital group Lindenhof Group.
January 29, 2026
Gilde Healthcare-backed medtech group acquires Rudischhauser
Netherlands-based thematic healthcare investor Gilde Healthcare has acquired Rudischhauser, a Germany-based surgical instruments and implants contract manufacturer, through its specialist contract manufacturing group for surgical instruments, Surgical Precision Instruments (SPI).
January 29, 2026
Digital healthcare provider Oviva closes €200 million Series D funding round
European digital healthcare provider Oviva has raised €200 million in a Series D financing round, led by Stockholm-headquartered investment firm Kinnevik.
January 28, 2026
Australian competition authority reviewing Ramsay’s acquisition of NCPH from Healthscope
The Australian Competition and Consumer Commission (ACCC) is reviewing the acquisition by Australia’s largest for-profit hospital group, Ramsay Health Care, of Canberra-based National Capital Private Hospital (NCPH), the biggest asset that is being sold off in the liquidation of Healthscope, which was Australia’s second largest hospital group until it went bust last year.
January 26, 2026
Spanish regulator gives conditional approval to Ribera Salud’s acquisition of Clínica Gaias
The Spanish National Markets and Competition Commission (CNMC) has conditionally approved the Spanish hospital group Ribera Salud’s acquisition of diagnostic centre Clínica Gaias Lugo.
January 22, 2026
Australian competition regulator is reviewing GE Healthcare’s Intelerad acquisition
The Australian Competition and Consumer Commission (ACCC) is reviewing the acquisition of medical imaging software company Intelerad by US medtech firm GE Healthcare. The acquisition of Intelerad by GE from London-based private equity firm Hg Capital was announced in November 2025 in a deal worth $2.3 billion (~€1.97 billion). Hg is completely exiting its majority […]
January 22, 2026
CMA investigates Welltower’s UK care home acquisitions
The UK Competition and Markets Authority (CMA) has launched an investigation into acquisitions by US healthcare REIT Welltower of care homes managed by for-profit UK care operators Barchester, HC-One, Aria Care, and Danforth Care.
